Revision of the 'missed pill' rules

Journal of Family Planning and Reproductive Health Care

Volumn 37, Issue 3, 2011, Pages 128-131

  Mansour, Diana ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; TRIPHASIC CONTRACEPTIVE AGENT;

EMERGENCY CONTRACEPTION; FEMALE; HUMAN; NOTE; ORAL CONTRACEPTION; OVULATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; TREATMENT FAILURE; UNITED KINGDOM; UNITED STATES; UNPLANNED PREGNANCY; WORLD HEALTH ORGANIZATION;

CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ETHINYL ESTRADIOL; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 79961068155     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2011-0074     Document Type: Note

References (27)

1. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Faculty statement from the CEU on a new publication: WHO Seierted Practice Recommendations for Contraceptive Use Update. Missed pills: new recommendations. J Fam Plann Reprod Health Care 2005;31:153-155.
2. Mansour D, Fraser IS. Missed contraceptive pills and the critical pill-free interval. Lancet 2005;365:1670-1671. (Pubitemid 40719100)
3. Guillebaud J. Faculty statement from the CEU and fpa 'Your Guide to the Combined Pill' leaflet, April 2005, based on the WHO's 2004 Guidance re advice for missed COCs [Letter]. / Fam Plann Reprod Health Care 2005;31:252.
4. Hollingworth BA, Marfleet C. CEU statement on missed pills [Letter]. J Fam Plann ReprodHealth Care 2005;31:253. (Pubitemid 41044443)
5. Killick SR. When is a pill missed? [Letter]. J Fam Plann Reprod Health Care 2005;31:254.
6. Smith D. Missed pills [Letter]. J Fam Plann Reprod Health Care 2005;31:253.
7. van der Westhuizen M, Hall D. Are affluent, well-educated, career-orientated women knowledgeable users of the oral contraceptive pill? J Fam Plann ReprodHealth Care 2005;31:307-309.
8. Willis C, Whirwell I. Missed pill guidelines [Letter]. J Fam Plann ReprodHealth Care 2005;31:336.
9. Merck, Sharp and Dohme. Marvelon: Summary of Product Characteristics. 2009. http://www.medicines.org.uk/emc/medicine/5383/SPC/ [accessed 22 January 2011].
10. Penney G, Brechin S, Glasier A, et al. Missed contraceptive pill recommendations. Lancet 2005;366:1264.
11. Creinin MD, Lippman JS, Eder SE, et al. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol. Contraception 2002;66:147-152. (Pubitemid 35217863)
12. Elomaa K, Rolland R, Brosens I, et al. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. Am J Obstet Gynecol 1998;179:41-46. (Pubitemid 28394471)
13. Hamilton CJ, Hoogland HJ. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. Am J Obstet Gynecol 1989;161:1159-1162. (Pubitemid 20007673)
14. Hedon B, Cristol P, Plauchut A, et al. Ovarian consequences of the transient interruption of combined oral contraceptives. Int J Fertil 1992;37:270-276.
15. Killick SR, Bancroft K, Oelbaum S, et al. Extending the duration of the pill-free interval during combined oral contraception. Adv Contracept 1990;6:33-40. (Pubitemid 20193659)
16. Smith SK, Kirkman RJ, Arce BB, et al. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Contraception 1986;34:513-522. (Pubitemid 17205338)
17. Elomaa K, Lähteenmäki P. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. Contraception 1999;60:275-279. (Pubitemid 30100603)
18. Baerwald AR, Olatunbosun OA, Pierson RA. Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use. Contraception 2004;70:371-377. (Pubitemid 39422513)
19. Pierson RA, Archer DF, Moreau M, et al. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertil Steril 2003;80:34-42. (Pubitemid 36808853)
20. Dinger J, Minh TD, Buttmann N, et al. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol 2011;117:33-40.
21. Birtch RL, Olatunbosun OA, Pierson RA. Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use. Contraception 2006;73:235-243. (Pubitemid 43202172)
22. Klipping C, Duijkers I, Trummer D, et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16-25.
23. Curtis KM, Chrisman CE, Mohllajee AP, et al. Effective use of hormonal contraceptives: part I: combined oral contraceptive pills. Contraception 2006;73:115-124. (Pubitemid 43087761)
24. Medicines and Healthcare products Regulatory Authority (MHRA). MHRA UK Public Assessment Report. Combined Oral Contraceptives (The Pill): When to Start Taking The Pill, and Missed Pill Advice. May 2011. http://www.mhra.gov.uk/ Safetyinformation/ Generalsafetyinformationandadvice/Product-specificinformation andadvice/Product-specificinformationandadvice-G-L/Hormonalcontraceptives/ index.htm [accessed 13 May 2011].
25. Trussell J. Understanding contraceptive failure. Best Pract Res Clin Obstet Gynaecol 2009;23:199-209.
26. World Health Organization. Selected Practice Recommendations for Contraceptive Use (2nd edn). 2004. http://whqlibdoc.who.int/publications/2004/ 9241562846.pdf [accessed 30 January 2011].
27. Dinger J. Comparative effectiveness of combined oral contraceptives in adolescents [Letter]. J Fam Plann Reprod Health Care 2011;37:118.